UNITECH INTERNATIONAL LTD. is a Chemicals & Petrochemicals company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
| ₹ crore · consolidated | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 26 | 25 | 23 | 5 | 0 |
| EBITDA (ex other income) | 4 | 4 | (7) | (26) | (1) |
| margin % | 17.3 | 16.8 | (32.3) | (512.8) | (8182.2) |
| Owners' profit | (0) | (0) | (12) | (27) | (2) |
| EPS, as reported (₹) | (0.27) | 0.00 | 11.67 | 0.00 | 2.19 |
| ROE % · ROCE % | 0.0 · 0.0 | 0.0 · 0.0 | (1501.6) · (58.6) | 102.9 · (1925.9) | 7.7 · 316.5 |
| Debt / equity (x) | 2.67 | 2.31 | 36.91 | (1.06) | (0.98) |
| Cash from operations | 3 | 8 | (10) | 1 | (0) |
| Capex | 0 | (0) | 0 | 0 | 0 |
| ₹ crore | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4 | 1 | 1 | (0) | 0 | 0 | 0 | 0 |
| Profit before tax | (1) | (0) | (1) | (6) | (1) | (0) | (1) | (0) |
| Net profit | — | (0) | (1) | (6) | — | (0) | (1) | (0) |
| EPS (₹) | (1.49) | 0.00 | 0.00 | 0.00 | (0.54) | 0.00 | 0.88 | 0.34 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| PIDILITE INDUSTRIES LTD | 1,59,479 | 60.2 | 14.43 | 42.3 | 22.4 | 28.0 | 14.9 | 28.6 |
| SRF LTD | 73,583 | 34.0 | 5.24 | 22.7 | 13.1 | 13.1 | 13.4 | 25.2 |
| GUJARAT FLUOROCHEM LTD | 52,514 | 85.7 | 6.64 | 41.5 | 7.3 | 8.7 | 13.5 | 27.7 |
| NAVIN FLUORINE INT. LTD | 43,836 | 55.4 | 11.03 | 39.5 | 16.7 | 16.4 | 23.0 | 37.5 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 1 Sept 2026 · 16th CoC meeting scheduled on 2 September 2026 under CIRP | regulatory legal | medium | — | — |
| 27 Aug 2026 · 15th Committee of Creditors meeting scheduled on 20 Aug 2026 | regulatory legal | high | — | — |
| 27 Aug 2026 · CoC approves 60-day extension of CIRP period | regulatory legal | high | — | — |
| 19 Aug 2026 · 12th CoC meeting held under CIRP; all 5 agenda items approved | regulatory legal | high | — | — |
| 12 Aug 2026 · CIRP update: 14th CoC meeting rescheduled to 11 August 2026 | regulatory legal | medium | — | — |
| 8 Aug 2026 · CoC meeting under CIRP deferred to 10 August 2026 | regulatory legal | medium | — | — |
| 1 Aug 2026 · 13th CoC Meeting Held Under Ongoing CIRP Process | regulatory legal | high | — | — |
| 17 Jul 2026 · 12th Committee of Creditors meeting held under CIRP | regulatory legal | high | — | — |
| 17 Jul 2026 · CoC approves 60-day extension of CIRP period | regulatory legal | high | — | — |
| 11 Jul 2026 · CoC meeting outcomes during ongoing CIRP process | regulatory legal | high | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| AETHER INDUSTRIES LIMITED | 22,229 | 94.3 | 9.05 | 60.4 | 8.9 | 11.4 | — | 33.8 |
| DEEPAK NITRITE LTD | 21,769 | 27.8 | 3.71 | 22.4 | 9.4 | 10.2 | 12.6 | 21.5 |
| ATUL LTD | 18,401 | 23.1 | 2.92 | 14.9 | 10.9 | 13.3 | 10.9 | 23.1 |
| AARTI INDUSTRIES LTD | 17,846 | 33.6 | 3.00 | 18.8 | 7.0 | 4.4 | 13.0 | 16.2 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 4.6 | 23.4 | 5 of 103 | 96% |
| ROCE | 317.1 | 10.3 | 2 of 108 | 99% |
| ROE | 7.7 | 8.1 | 55 of 101 | 46% |
| Debt / Equity | (1.0) | 0.2 | 1 of 101 | 100% |
| Profit growth | 94.0 | 55.1 | 30 of 92 | 68% |
| Market cap | 3 | 732 | 106 of 107 | 1% |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
